The cholesterol-lowering medication, Simvastatin, commonly used to prevent cardiovascular diseases, has now been observed to play a significant dual role in the field of stem cell research. A study recently published in the International Dental Journal examines the impact of Simvastatin on dental stem cells and its unexpected behavior in influencing cell viability and mobility. This news article delves into the intriguing findings which demonstrate that while Simvastatin prompts cell death through apoptosis, it simultaneously impedes cell migration, findings that are highly pertinent as the medical community explores regenerative therapies.

The study, conducted by a team of researchers from the Center of Excellence for Dental Stem Cell Biology and Department of Anatomy, Faculty of Dentistry at Chulalongkorn University, Bangkok, Thailand, specifically focused on stem cells isolated from apical papillae, also known as SCAPs. These cells are a type of dental stem cell holding immense potential in regenerative endodontics, a field dedicated to saving teeth through biologically based therapies.

Prior research has suggested that simvastatin can impact stem cell behavior, but until now, the specifics of this interaction, especially concerning SCAPs, were not well documented. The Thai research team meticulously explored this by isolating SCAPs and assessing their viability and proliferation with live/dead and MTT assays respectively. Migration was studied through scratch assays, and cell cycle progression alongside apoptosis was evaluated using flow cytometry analysis.

The findings revealed that simvastatin did not exhibit cytotoxic effects at concentrations ranging from 100 to 1000 nM. However, the study took an intriguing twist when it was observed that simvastatin reduced cell numbers substantially at days 3 and 7 of the experiment. Notably, there was a marked decrease in colony formation, indicative of a decline in the proliferation potential of the SCAPs in the presence of simvastatin.

Furthermore, apoptosis significantly increased by day 7, with a statistically significant rise in the sub-G0 population, which represents a stage of cell death. Equally interesting was the observation that simvastatin throttled the migratory capabilities of the SCAPs in a dose-dependent manner. The findings suggested that simvastatin affects the vitality, growth, and migration of SCAPs, with a considerable reduction in cell viability possibly attributed to apoptosis induction.

This study’s importance cannot be understated as apoptosis, a form of programmed cell death, plays a crucial role in maintaining the equilibrium in cell populations within tissues, especially during development and tissue regeneration. The migration of stem cells is also a fundamental aspect of regeneration as these cells need to move to the site of injury to mediate repair.

These nuances of simvastatin’s effects raise important questions for regenerative medicine. The ability of simvastatin to induce apoptosis could be harnessed to eliminate unwanted or damaged cells, while its effect on cell migration could either be a hindrance or help, depending on whether immobilization of cells is desired in a given therapeutic context.

The authors state that there’s no conflict of interest disclosed in this study, reinforcing the neutrality and credibility of their findings. The article, vibrant with insightful data and implications, promises a new vista for understanding and utilizing pharmaceutical compounds in the field of stem cell research.

The DOI of this remarkable study is 10.1016/j.identj.2023.10.015, and it was published ahead of print on January 14, 2024. The bibliographic citation can be accessed with the reference number S0020-6539(23)00960-7.

The implication of this study stretches beyond the medical and scientific communities, appealing to pharmaceutical manufacturers, health policy makers, and dental practitioners seeking innovative solutions for dental and skeletal regenerations.

1. Rewthamrongsris, P., Phothichailert, S., Chokechanachaisakul, U., Kornsuthisopon, C., & Osathanon, T. (2024). Simvastatin Induces Apoptosis but Attenuates Migration in SCAPs. International Dental Journal.


1. Simvastatin effects on stem cells
2. SCAPs viability and migration
3. Regenerative endodontics
4. Dental stem cell research
5. Apoptosis induction in SCAPs